SkyNet de Colombia and SES Networks Ramp Up Connectivity Services to Aid Worst-hit COVID-19 Colombian Amazonas Communities
8.6.2020 09:50:00 EEST | Business Wire | Press release
Local residents, businesses, government entities and the San Rafael de Leticia Hospital in the Colombian Amazonas are experiencing efficient, reliable and high-performing Internet connectivity as Colombian services provider SkyNet and SES Networks extended their partnership and increased network capacity within days to support COVID-19 mitigation efforts. SkyNet leveraged SES Networks’ Signature Solutions to deliver connectivity services to the Colombian region with the highest COVID-19 infection rate and lowest internet penetration in the country, SES announced today.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200607005067/en/
SkyNet de Colombia and SES Networks Ramp Up Connectivity Services to Aid Worst-hit COVID-19 Colombian Amazonas Communities (Photo: Business Wire)
The Colombian Ministry of Telecommunications (MinTIC) selected SkyNet to install, operate and maintain five free Wi-Fi hotspots in Leticia to connect residents, as well as a high -speed dedicated broadband service for the local hospital’s medical and administrative teams to carry out telemedicine sessions and other eHealth activities to effectively respond to the crisis. These services are enabled by SES’s unique low-latency high-throughput O3b medium earth orbit (MEO) satellite constellation, which delivers fibre-equivalent performance to support high-performance data networks and solutions – including cloud services and applications.
According to the MinTIC, the enhanced broadband connectivity service allows local medical staff to communicate with other health professionals in Colombia’s capital Bogotá or institutions around the world. They benefit from tele-consultation services, collaboration with remote teams for faster speed to diagnosis, treatments and follow-ups for patients in the area.
SkyNet has been leveraging SES’s O3b MEO services since 2015 to connect remote Colombian regions, when they first delivered high-speed internet access and fibre-like services in Leticia empowering the local community, businesses and tourism industry. Today, SkyNet has become the incumbent provider in the area delivering reliable connectivity services to hundreds of households and businesses in Leticia, while also enabling access to e-learning platforms for a significant number of local students who cannot travel to attend classes due to the impact of COVID-19.
Additionally, SkyNet is now also leveraging the geostationary SES-14 satellite to enable one Wi-Fi zone for residents, local business and the municipal mayor´s office in Puerto Nariño. This Wi-Fi zone is the local residents’ only way to connect to the Internet as their 2G mobile coverage does not support mobile broadband connectivity.
“Our responsibility and commitment is to have a Colombia that is Naturally Connected. We return to our project in the Amazonas where since 2015 we have linked Leticia’s population to the world helping promote tourism, the main source of income for its inhabitants,” said Diego Moreno Lugo CEO of SkyNet of Colombia. “Today, information and communication technologies bring access to education, remote work and even telemedicine, and it is evident that with the health crisis of COVID-19, remote Colombian regions are worst-hit due to the lack of connectivity. The O3b service experience we are giving is very close to fibre optics and it is the best answer in satellite technology today. It brings great social impact, since it expands opportunities for education and health, and it has been without a doubt a great advancement for this entire community. As a company, we are proud to connect those sometimes-forgotten places.”
“The COVID-19 crisis has impacted us all and we’re committed to doing our part to support our customers and the local communities they serve wherever possible,” said Omar Trujillo, Vice President of Sales for Fixed Data Americas at SES Networks. “By enabling SkyNet to deliver reliable, high-speed broadband connectivity to historically underserved communities, businesses and healthcare workers in the Amazon region when they need it most is extremely gratifying. We are glad that our services are keeping loved ones connected and enabling healthcare workers with tools that empower them to do their job.”
Follow us on:
Social Media
Blog
Media Library
About SES
SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world. As the leader in global content connectivity solutions, SES operates the world’s only multi-orbit constellation of satellites with the unique combination of global coverage and high performance, including the commercially-proven, low-latency Medium Earth Orbit O3b system. By leveraging a vast and intelligent, cloud-enabled network, SES is able to deliver high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to the world’s leading telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners. SES’s video network carries over 8,300 channels and has an unparalleled reach of 367 million households, delivering managed media services for both linear and non-linear content. The company is listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com.
About SkyNet de Colombia
SkyNet is a Colombian company with more than 20 years in the satellite telecommunications market. SkyNet creates solutions that help customers grow, even in the most remote places in the country; enabling them with the widest spectrum of satellite solutions, based on its own technology and also on services from world-leading providers.
By 2020 SkyNet has established as a priority to have a country where everyone is 'Naturally Connected', consolidating its portfolio with the development of the different Bands of services, an electromagnetic spectrum frequency used in satellite communications that implements more capacity, better coverage and affordable prices. More information: https://www.sky.net.co/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200607005067/en/
Contact information
For further information please contact:
Suzanne Ong
External Communications
Tel. +352 710 725 500
suzanne.ong@ses.com
SussyForero
SkyNet de Colombia
Tel. +573002085715
sussyforero@outlook.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 17:00:00 EEST | Press release
PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpinned by global capacity, technical expertise, deep scientific knowledge, and an industry-leading quality and regulatory track record. This press release features multimedia. View the full release here: https://www.
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 16:53:00 EEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 16:00:00 EEST | Press release
Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world. “Data is only valuable when it’s activated,” said Steve Lucas, Chairman and CEO, Boomi. “At Boomi World 2026, we
Axinn Appoints Rachael Philbin as Chief Innovation Officer27.4.2026 16:00:00 EEST | Press release
Axinn, Veltrop & Harkrider LLP today announced the appointment of Rachael Philbin as Chief Innovation Officer, reinforcing the firm’s continued investment in advanced solutions and technology for legal services delivery. Philbin joins from Proskauer Rose LLP, where she served as Innovation & Transformation Officer. Based in Axinn's New York office, she will lead the firm’s AI and legal technology initiatives as well as knowledge management efforts, accelerating adoption and integration across its antitrust, intellectual property, and litigation practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427277725/en/ Rachael Philbin joins Axinn, Veltrop & Harkrider LLP as Chief Innovation Officer. “As Axinn continues to grow, we are making deliberate investments in the capabilities that enable our lawyers to deliver service and results at the highest level in our clients’ complex matters,” said Jeny Maier, managing partner
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 16:00:00 EEST | Press release
Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug conjugates (ADCs). Central to Araris’ approach is its proprietary AraLinQ™ ADC technology, which enables the creation of stable and site-specific ADCs using standard antibodies with scalable manufacturing
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
